Immuno-Biological Laboratories Co., Ltd. (4570.T)
JPY 458.0
(-2.35%)
JPY 458.0
(-2.35%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 816.7 Million | 794.62 Million | 647.57 Million | 602.74 Million | 576 Million |
| Cost of Revenue | 299.4 Million | 267.9 Million | 270.87 Million | 255.89 Million | 360 Million |
| Gross Profit | 517.29 Million | 526.71 Million | 376.69 Million | 346.85 Million | 216 Million |
| Operating Expenses | 412.99 Million | 468.33 Million | 498.91 Million | 587.83 Million | 875 Million |
| Selling, General and Administrative Expenses | 7.42 Million | 8.74 Million | 4.76 Million | 8.85 Million | 494 Million |
| Research and Development Expenses | 129.98 Million | 179.65 Million | 188.58 Million | 267.11 Million | 318 Million |
| Other Expenses | 275.58 Million | -6.99 Million | 5.54 Million | 16.01 Million | - |
| Cost and Expenses | 712.39 Million | 736.24 Million | 769.79 Million | 843.72 Million | 1.23 Billion |
| Operating Income | 104.29 Million | 58.37 Million | -122.21 Million | -240.98 Million | -596 Million |
| Interest Expense | 1.13 Million | 1.07 Million | 641 Thousand | 749 Thousand | 932 Thousand |
| Income Tax Expense | -62.05 Million | 9.11 Million | 8.62 Million | 8.19 Million | 9 Million |
| Earnings before Tax | 124.64 Million | -280.61 Million | -250.14 Million | -310.63 Million | -659 Million |
| Net Income | 186.69 Million | -289.73 Million | -258.76 Million | -318.82 Million | -668 Million |
| Earnings Per Share Basic | 20.05 | -31.11 | -27.78 | -34.23 | -75.99 |
| Earnings Per Share Diluted | 20.05 | -31.11 | -27.78 | -34.23 | -75.99 |
| Weighted Average Shares Outstanding | 9.31 Million | 9.31 Million | 9.31 Million | 9.31 Million | 8.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.31 Million | 9.31 Million | 9.31 Million | 9.31 Million | 8.79 Million |
| Gross Margin | 0.63 | 0.66 | 0.58 | 0.58 | 0.38 |
| EBIT Margin | 0.16 | -0.18 | -0.41 | -0.52 | -0.11 |
| Profit Margin | 0.23 | -0.36 | -0.40 | -0.53 | -1.16 |
| EBITDA | 128.1 Million | -332 Million | -249.5 Million | -309.88 Million | -63 Million |
| Earnings Before Tax Margin | 0.13 | 0.07 | -0.19 | -0.40 | -1.03 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 229 Million | 268.29 Million | 816.7 Million | 182.88 Million | 188.32 Million | 177.18 Million |
| Cost of Revenue | 75 Million | 77.53 Million | 299.4 Million | 71.62 Million | 75.85 Million | 74.38 Million |
| Gross Profit | 154 Million | 190.75 Million | 517.29 Million | 111.26 Million | 112.47 Million | 102.8 Million |
| Operating Expenses | 98 Million | 97.21 Million | 412.99 Million | 115.13 Million | 98.41 Million | 102.22 Million |
| Selling, General and Administrative Expenses | 102 Million | 33 Million | - | 115 Million | 98 Million | 96 Million |
| Research and Development Expenses | - | 129 Million | - | 33.57 Million | 29.26 Million | 33.79 Million |
| Other Expenses | - | 2.71 Million | 6.5 Million | 2.37 Million | 946 Thousand | 467 Thousand |
| Cost and Expenses | 173 Million | 174.75 Million | 712.39 Million | 186.75 Million | 174.27 Million | 176.61 Million |
| Operating Income | 52 Million | 93.54 Million | 104.29 Million | -3.86 Million | 14.05 Million | 576 Thousand |
| Interest Expense | - | 302 Thousand | 1.13 Million | 295 Thousand | 267 Thousand | 266 Thousand |
| Income Tax Expense | 5 Million | -66.48 Million | -62.05 Million | 1.42 Million | 1.42 Million | 1.58 Million |
| Earnings before Tax | 56 Million | 99.62 Million | 124.64 Million | -4.84 Million | 17.12 Million | 12.74 Million |
| Net Income | 51 Million | 166.1 Million | 186.69 Million | -6.27 Million | 15.69 Million | 11.16 Million |
| Earnings Per Share Basic | 5.48 | 17.82 | - | -0.67 | 1.61 | 1.19 |
| Earnings Per Share Diluted | 5.48 | 17.82 | - | -0.67 | 1.61 | 1.19 |
| Weighted Average Shares Outstanding | 9.31 Million | 9.31 Million | 9.31 Million | 9.31 Million | 9.31 Million | 9.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.31 Million | 9.31 Million | 9.31 Million | 9.31 Million | 9.31 Million | 9.31 Million |
| Gross Margin | 0.67 | 0.71 | 0.63 | 0.61 | 0.60 | 0.58 |
| EBIT Margin | 0.23 | 0.37 | - | -0.03 | 0.09 | 0.04 |
| Profit Margin | 0.22 | 0.62 | 0.23 | -0.03 | 0.08 | 0.06 |
| EBITDA | 52.5 Million | 99.92 Million | - | -4.71 Million | 17.38 Million | 6.99 Million |
| Earnings Before Tax Margin | 0.23 | 0.35 | 0.13 | -0.02 | 0.07 | 0.00 |
INPOY
4009
6573
6798
WKHS
SOMANYCERA